Systemic Lupus and Belimumab Treatment

Treatment of Systemic Lupus and Belimumab 

Instruction

Write a Literature review using the following sources.

Anjo, C., Mascaró Jr, J.-M., Espinosa, G., Cervera, R., & Mascaró, J.-M., Jr. (2019). Effectiveness and safety of belimumab in patients with
systemic lupus erythematosus in a real-world setting. Scandinavian Journal of Rheumatology, 48(6), 469–473. https://doiorg.cotc.idm.oclc.org/10.1080/03009742.2019.1603324

Blair, H. A., & Duggan, S. T. (2018). Belimumab: A Review in Systemic Lupus Erythematosus. Drugs, 78(3), 355–366. https://doiorg.cotc.idm.oclc.org/10.1007/s40265-018-0872-z

Dashiell-Aje, E., Harding, G., Pascoe, K., DeVries, J., Berry, P., & Ramachandran, S. (2018). Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus. Patient, 11(1), 119–129. https://doi-org.cotc.idm.oclc.org/10.1007/s40271-017-0276-2

Parodis, I., Johansson, P., Gomez, A., Soukka, S., Emamikia, S., & Chatzidionysiou, K. (2019). Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus. Rheumatology, 58(12), 2170–2176. https://doiorg.cotc.idm.oclc.org/10.1093/rheumatology/kez191

Samotij, D., & Reich, A. (2019). Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review. BioMed Research
International, 1–17.https://doi-org.cotc.idm.oclc.org/10.1155/2019/8142368